2020 ASCO Virtual Direct™ Highlights


 

2020 ASCO Highlights on Targeted Therapy in Early Stage EGFR+ NSCLC: Adjuvant Osimertinib, Adjuvant EGFR TKI Gefitinib vs. Standard Chemo

17 views
September 22, 2020
0 Comments
Login to view comments. Click here to Login